Active · per the CBE, 16 November 2026

OSIVAX Belgique

BE0707772871

Rechtspersoon Private limited company 1 establishment

OSIVAX Belgique is a research organisation in Liège. Private Limited, started on 4 October 2018, 1 establishment.

Rue des Chasseurs-Ardennais 7, 4031 Liège

Behind the company: OSIVAX SAS.

Active for

8 year, 1 month

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Two loss years in a row NBB

    Negative result in 2024 and 2025.

Financials

Financial year 2025

OSIVAX Belgique from Liège, company number BE0707772871, closed financial year 2025 with a result of € -2.8 million after tax. For that financial year OSIVAX Belgique recorded a gross margin of € 3.9 million and equity of € 13.3 million. Compared with financial year 2024, the result moved from € -2.6 million to € -2.8 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Healthy

€ 13.3 million

▼ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -2.8 million

▼ 10 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.5 million

▲ 121% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.8 million.

People and assets in 2025

Full-time equivalents

8.7

▲ 1.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.3 million

▲ 36% vs 2024

€ 148,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 10,706

▲ 2% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 14 years to go

€ 1.5 million

▲ 161% vs 2024

€ 104,517 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.

Owed to suppliers

€ 477,363

▲ 88% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 129,496

▲ 13% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
2022202320242025Change 2024 → 2025
Gross margin € 1,794,605 € 1,109,402 € 1,142,157 € 3,902,281 ▲ 242%
Profit after taxes € -2,924,097 € -2,882,187 € -2,572,356 € -2,837,923 ▼ € 265,567
Equity € 10,931,951 € 8,924,764 € 16,176,732 € 13,338,809 ▼ 18%
Total debts € 3,577,733 € 2,217,550 € 2,238,194 € 3,621,172 ▲ 62%
Cash € 1,130,270 € 695,486 € 664,762 € 1,469,179 ▲ 121%
Retained profit € -9,271,367 € -12,153,554 € -14,725,910 € -2,837,923 ▲ € 11.9 million
Bank debt € 0 € 0 € 577,500 € 1,505,878 ▲ 161%
Balance sheet total € 14,509,684 € 11,142,314 € 18,414,926 € 16,959,982 ▼ 8%
Employees (FTE) 4.7 6.2 7.1 8.7 ▲ 1.6

By gross margin, OSIVAX Belgique ranks 1st of 73 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in the province of Liège that publish figures (fiscal year 2025).

Key figures of OSIVAX Belgique, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to OSIVAX Belgique?

What happened at OSIVAX Belgique in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 2.8 million. filed late Source: NBB ↗
  • OSIVAX SAS became a director. NBB
  • Capital increase of € 2.7 million, published in the Gazette. Source: Staatsblad ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Liège. KBO

In short

From € 2.9 million loss in 2022 to € 2.8 million loss in 2025.

On average € 448,500 of value added per employee in 2025.

Management

OSIVAX 100%
OSIVAX Belgique

Behind OSIVAX Belgique is OSIVAX SAS. The shares are held by OSIVAX (100%).

Directors

According to the 2025 annual accounts

OSIVAX SAS

Director · represented by LEVERT Alexandre

since 2020

Shareholders

OSIVAX

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Chasseurs-Ardennais 7

4031 Liège

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in the province of Liège

Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 94 active companies in the province of Liège, largest first.

TELIX INNOVATIONS

€ 243.8 million revenue · 2025 · Herstal

KANEKA EUROGENTEC

€ 49.4 million revenue · 2026 · Seraing

DIAGENODE

€ 11.9 million revenue · 2025 · Seraing

LaCAR MDx technologies

€ 8.1 million revenue · 2025 · Liège

MDxHealth

€ 4.2 million revenue · 2025 · Herstal

PDC line Pharma

€ 2.9 million gross margin · 2024 · Liège

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • OSIVAX(enige oprichter / enige vennoot) 100%

Details

Company number
0707.772.871
VAT number
BE 0707.772.871
Registered office
Rue des Chasseurs-Ardennais 7, 4031 Liège
Names & denominations
OSIVAX Belgique
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 October 2018
Peppol
Active · Active since 9 Jan 2026
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Frequently asked questions

What does OSIVAX Belgique do?
OSIVAX Belgique is a research organisation in Liège. Private Limited, started on 4 October 2018, 1 establishment.
What is the address of OSIVAX Belgique?
The registered office of OSIVAX Belgique is located at Rue des Chasseurs-Ardennais 7, 4031 Liège.
Is OSIVAX Belgique still active?
Yes. According to the CBE (16 November 2026) OSIVAX Belgique is active, legal situation “Normale toestand”, started on 4 October 2018.
Is OSIVAX Belgique registered on Peppol?
Yes, OSIVAX Belgique is registered on the Peppol network with ID 0208:0707772871.
What is the enterprise number of OSIVAX Belgique?
The enterprise number of OSIVAX Belgique is BE0707772871.
When was OSIVAX Belgique founded?
OSIVAX Belgique was founded on 4 October 2018.